{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T11:16:36Z","timestamp":1767611796825},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13014-015-0575-5","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T20:48:56Z","timestamp":1451422136000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy"],"prefix":"10.1186","volume":"10","author":[{"given":"Christian","family":"Thieke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Sterzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Roeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyer","family":"Safi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter E.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"575_CR1","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21:2636\u201344.","journal-title":"J Clin Oncol"},{"key":"575_CR2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.lungcan.2013.11.026","volume":"83","author":"C Cao","year":"2014","unstructured":"Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer. 2014;83:240\u20135.","journal-title":"Lung Cancer"},{"key":"575_CR3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0360-3016(02)04151-2","volume":"55","author":"A Ahamad","year":"2003","unstructured":"Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2003;55:768\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"575_CR4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","volume":"8","author":"DR Gomez","year":"2013","unstructured":"Gomez DR, Hong DS, Allen PK, Welsh JS, Mehran RJ, Tsao AS, et al. Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma. J Thorac Oncol. 2013;8:238\u201345.","journal-title":"J Thorac Oncol"},{"key":"575_CR5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/JTO.0b013e3182199819","volume":"6","author":"A Chi","year":"2011","unstructured":"Chi A, Liao Z, Nguyen NP, Howe C, Gomez D, Jang SY, et al. Intensity-modulated radiotherapy after extrapleural pneumonectomy in the combined-modality treatment of malignant pleural mesothelioma. J Thorac Oncol. 2011;6:1132\u201341.","journal-title":"J Thorac Oncol"},{"key":"575_CR6","first-page":"428","volume":"1","author":"C Cao","year":"2012","unstructured":"Cao C, Tian D, Manganas C, Matthews P, Yan TD. Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg. 2012;1:428\u201337.","journal-title":"Ann Cardiothorac Surg"},{"key":"575_CR7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2011.11.057","volume":"83","author":"PR Patel","year":"2012","unstructured":"Patel PR, Yoo S, Broadwater G, Marks LB, Miles EF, D\u2019Amico TA, et al. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2012;83:362\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"575_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2011.09.025","volume":"101","author":"S Tonoli","year":"2011","unstructured":"Tonoli S, Vitali P, Scotti V, Bertoni F, Spiazzi L, Ghedi B, et al. Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series. Radiother Oncol. 2011;101:311\u20135.","journal-title":"Radiother Oncol"},{"key":"575_CR9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.lungcan.2011.05.012","volume":"74","author":"A Sylvestre","year":"2011","unstructured":"Sylvestre A, Mah\u00e9 MA, Lisbona A, Zefkili S, Savignoni A, Bonnette P, et al. Mesothelioma at era of helical tomotherapy: results of two institutions in combining chemotherapy, surgery and radiotherapy. Lung Cancer. 2011;74:486\u201391.","journal-title":"Lung Cancer"},{"key":"575_CR10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.canrad.2013.06.045","volume":"17","author":"J Helou","year":"2013","unstructured":"Helou J, Cl\u00e9ment-Colmou K, Sylvestre A, Campion L, Amessis M, Zefkili S, et al. Helical tomotherapy in the treatment of malignant pleural mesothelioma: The impact of low doses on pulmonary and oesophageal toxicity. Cancer Radiother. 2013;17:755\u201362.","journal-title":"Cancer Radiother"},{"key":"575_CR11","first-page":"142","volume":"25","author":"R Fahrner","year":"2012","unstructured":"Fahrner R, Ochsenbein A, Schmid RA, Carboni GL. Long term survival after trimodal therapy in malignant pleural mesothelioma. Swiss Med Wkly. 2012;25:142.","journal-title":"Swiss Med Wkly"},{"key":"575_CR12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1748-717X-9-32","volume":"9","author":"J Krayenbuehl","year":"2014","unstructured":"Krayenbuehl J, Dimmerling P, Ciernik IF, Riesterer O. Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma. Radiat Oncol. 2014;9:32.","journal-title":"Radiat Oncol"},{"key":"575_CR13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2407-13-22","volume":"13","author":"R Federico","year":"2013","unstructured":"Federico R, Adolfo F, Giuseppe M, Lorenzo S, Martino DT, Anna C, et al. Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma. BMC Cancer. 2013;13:22.","journal-title":"BMC Cancer"},{"key":"575_CR14","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2007.04.076","volume":"84","author":"DC Rice","year":"2007","unstructured":"Rice DC, Stevens CW, Correa AM, Vaporciyn AA, Tsao A, Forster KM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007;84:1685\u201392.","journal-title":"Ann Thorac Surg"},{"key":"575_CR15","doi-asserted-by":"crossref","unstructured":"Stahel RA, Weder W, Riesterer O, Xyrafas A, Opitz I, Beyeler M, et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma (MPM) with or without hemithoracic radiotherapy: final results of the randomized multicenter phase II trial SAKK17\/04. European Society for Medical Oncology (ESMO), ESMO 2014 Congress, Madrid, Spain, LBA37 (late breaking abstract).","DOI":"10.1093\/annonc\/mdu438.65"},{"key":"575_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2009.03.011","volume":"92","author":"CA Kristensen","year":"2009","unstructured":"Kristensen CA, N\u00f8ttrup TJ, Berthelsen AK, Kjaer-Kristoffersen F, Rayn J, S\u00f8rensen JB, et al. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma. Radiother Oncol. 2009;92:96\u20139.","journal-title":"Radiother Oncol"},{"key":"575_CR17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","volume":"36","author":"PE Schil Van","year":"2010","unstructured":"Van Schil PE, Baas P, Gaafar R, Maat AP, Van de Pol M, Hasan B, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J. 2010;36:1362\u20139.","journal-title":"Eur Respir J"},{"key":"575_CR18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","volume":"65","author":"AM Allen","year":"2006","unstructured":"Allen AM, Czerminska M, J\u00e4nne PA, Sugarbaker DJ, Bueno R, Harris JR, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65:640\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"575_CR19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.radonc.2007.12.010","volume":"86","author":"F Sterzing","year":"2008","unstructured":"Sterzing F, Sroka-Perez G, Schubert K, M\u00fcnter MW, Thieke C, Huber P, et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol. 2008;86:251\u20137.","journal-title":"Radiother Oncol"},{"key":"575_CR20","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1120\/jacmp.v14i4.4130","volume":"14","author":"J Krayenbuehl","year":"2013","unstructured":"Krayenbuehl J, Riesterer O, Graydon S, Dimmerling P, Kloeck S, Ciernik IF. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy. J Appl Clin Med Phys. 2013;14:4130.","journal-title":"J Appl Clin Med Phys"},{"issue":"8","key":"575_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol. 2011;12(8):763\u201372.","journal-title":"Lancet Oncol"},{"issue":"11","key":"575_CR22","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/JTO.0b013e31818b174d","volume":"3","author":"G Hillerdal","year":"2008","unstructured":"Hillerdal G, Sorensen JB, Sundstr\u00f6m S, Riska H, Vikstr\u00f6m A, Hjerpe A. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study. J Thorac Oncol. 2008;3(11):1325\u201331.","journal-title":"J Thorac Oncol"},{"key":"575_CR23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2014.05.032","volume":"90","author":"A Rimner","year":"2014","unstructured":"Rimner A, Spratt DE, Zauderer MG, Rosenzweig KE, Wu AJ, Foster A, et al. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2014;90:394\u2013401.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"575_CR24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2013.10.013","volume":"83","author":"E Minatel","year":"2014","unstructured":"Minatel E, Trovo M, Polesel J, Baresic T, Bearz A, Franchin G, et al. Radical pleurectomy\/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up. Lung Cancer. 2014;83:78\u201382.","journal-title":"Lung Cancer"},{"key":"575_CR25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","volume":"91","author":"WW Chance","year":"2014","unstructured":"Chance WW, Rice DC, Allen PK, Taso AS, Fontanilla HP, Liao Z, et al. Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: Toxicity, patterns of failure, and a matched survival analysis. Int J Radiat Oncol Biol Phys. 2014;91:149\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-015-0575-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T21:51:40Z","timestamp":1567461100000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ro-journal.com\/content\/10\/1\/267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1186\/s13014-015-0575-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"267"}}